monalizumab   Click here for help

GtoPdb Ligand ID: 8323

Synonyms: humZ270 [8] | IPH-2201 | NN8765-3658
Immunopharmacology Ligand
Compound class: Antibody
Comment: Monalizumab (IPH2201) is a humanized IgG4κ anti-NKG2A (KLRC1, CD159a) monoclonal antibody being investigated as an anti-cancer treatment [4,7]. Administered intravenously or subcutaneously. Use of monalizumab is claimed in patent WO2016041947 (called IPH2201 in the patent) [1].
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Click here for help
Classification Click here for help
Compound class Antibody
International Nonproprietary Names Click here for help
INN number INN
10113 monalizumab
Synonyms Click here for help
humZ270 [8] | IPH-2201 | NN8765-3658
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 562
Other databases
GtoPdb PubChem SID 252166535
Search PubMed clinical trials monalizumab
Search PubMed titles monalizumab
Search PubMed titles/abstracts monalizumab